ZA200103483B - A method for reproducing molecular arrays. - Google Patents
A method for reproducing molecular arrays. Download PDFInfo
- Publication number
- ZA200103483B ZA200103483B ZA200103483A ZA200103483A ZA200103483B ZA 200103483 B ZA200103483 B ZA 200103483B ZA 200103483 A ZA200103483 A ZA 200103483A ZA 200103483 A ZA200103483 A ZA 200103483A ZA 200103483 B ZA200103483 B ZA 200103483B
- Authority
- ZA
- South Africa
- Prior art keywords
- molecules
- substrate
- array
- immobilised
- dna
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 37
- 238000003491 array Methods 0.000 title description 10
- 239000000758 substrate Substances 0.000 claims description 60
- 238000012546 transfer Methods 0.000 claims description 32
- 239000011324 bead Substances 0.000 claims description 17
- 230000000295 complement effect Effects 0.000 claims description 13
- 108091033319 polynucleotide Proteins 0.000 claims description 9
- 102000040430 polynucleotide Human genes 0.000 claims description 9
- 239000002157 polynucleotide Substances 0.000 claims description 9
- 229960002685 biotin Drugs 0.000 claims description 8
- 239000011616 biotin Substances 0.000 claims description 8
- 102000004169 proteins and genes Human genes 0.000 claims description 8
- 108090000623 proteins and genes Proteins 0.000 claims description 8
- 239000004065 semiconductor Substances 0.000 claims description 7
- 230000027455 binding Effects 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 229910052710 silicon Inorganic materials 0.000 claims description 5
- 239000010703 silicon Substances 0.000 claims description 5
- 230000005684 electric field Effects 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 4
- 101710185494 Zinc finger protein Proteins 0.000 claims description 2
- 102100023597 Zinc finger protein 816 Human genes 0.000 claims description 2
- 239000007787 solid Substances 0.000 claims description 2
- 238000011065 in-situ storage Methods 0.000 claims 1
- 239000002773 nucleotide Substances 0.000 claims 1
- -1 nucleotide triphosphates Chemical class 0.000 claims 1
- 239000001226 triphosphate Substances 0.000 claims 1
- 235000011178 triphosphate Nutrition 0.000 claims 1
- 108020004414 DNA Proteins 0.000 description 35
- 108020004635 Complementary DNA Proteins 0.000 description 12
- 238000010804 cDNA synthesis Methods 0.000 description 12
- 239000002299 complementary DNA Substances 0.000 description 12
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 10
- 239000011521 glass Substances 0.000 description 10
- 230000003993 interaction Effects 0.000 description 10
- 239000000243 solution Substances 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 230000008878 coupling Effects 0.000 description 6
- 238000010168 coupling process Methods 0.000 description 6
- 238000005859 coupling reaction Methods 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 235000020958 biotin Nutrition 0.000 description 5
- 108090001008 Avidin Proteins 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 108091034117 Oligonucleotide Proteins 0.000 description 4
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 102100033620 Calponin-1 Human genes 0.000 description 3
- 101000945318 Homo sapiens Calponin-1 Proteins 0.000 description 3
- 101000652736 Homo sapiens Transgelin Proteins 0.000 description 3
- 238000009396 hybridization Methods 0.000 description 3
- 239000010410 layer Substances 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- JJAHTWIKCUJRDK-UHFFFAOYSA-N succinimidyl 4-(N-maleimidomethyl)cyclohexane-1-carboxylate Chemical compound C1CC(CN2C(C=CC2=O)=O)CCC1C(=O)ON1C(=O)CCC1=O JJAHTWIKCUJRDK-UHFFFAOYSA-N 0.000 description 3
- 125000003396 thiol group Chemical group [H]S* 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- 101100257624 Arabidopsis thaliana SPS4 gene Proteins 0.000 description 2
- 102000053602 DNA Human genes 0.000 description 2
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 2
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 2
- RPNUMPOLZDHAAY-UHFFFAOYSA-N Diethylenetriamine Chemical compound NCCNCCN RPNUMPOLZDHAAY-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 238000002508 contact lithography Methods 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 239000003792 electrolyte Substances 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- BIGOJJYDFLNSGB-UHFFFAOYSA-N 3-isocyanopropyl(trimethoxy)silane Chemical group CO[Si](OC)(OC)CCC[N+]#[C-] BIGOJJYDFLNSGB-UHFFFAOYSA-N 0.000 description 1
- 108700020911 DNA-Binding Proteins Proteins 0.000 description 1
- 102000052510 DNA-Binding Proteins Human genes 0.000 description 1
- 101001024703 Homo sapiens Nck-associated protein 5 Proteins 0.000 description 1
- PEEHTFAAVSWFBL-UHFFFAOYSA-N Maleimide Chemical compound O=C1NC(=O)C=C1 PEEHTFAAVSWFBL-UHFFFAOYSA-N 0.000 description 1
- 239000012901 Milli-Q water Substances 0.000 description 1
- 102100036946 Nck-associated protein 5 Human genes 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 1
- 108020004682 Single-Stranded DNA Proteins 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 230000009833 antibody interaction Effects 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 238000005868 electrolysis reaction Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 238000003205 genotyping method Methods 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 239000012212 insulator Substances 0.000 description 1
- 238000011005 laboratory method Methods 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 238000002966 oligonucleotide array Methods 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 229910000077 silane Inorganic materials 0.000 description 1
- 238000002444 silanisation Methods 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 235000012431 wafers Nutrition 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Description
] ® WO 00/27521 PCT/GB99/63691 : Ce y 1 ) A METHOD FOR REPRODUCING MOLECULAR ARRAYS . Field of the Invention t This invention relates to a method for reproducing, or cloning, molecular arrays. : Background of the Invention
Much of cellular and molecular biology is based on specific non-covalent interactions between molecules, sometimes referred to as molecular recognition. These interactions are not permanent and are based mainly on hydrophobic interactions and hydrogen bonds, so that the binding together of two molecules is reversible. A molecule that recognises specifically another molecule can be defined as a cognate molecule or complement molecule. For a strand of DNA, this cognate can be a strand of complementary sequence. The molecule cognate can also be a protein, e.g. a transcription-regulating protein which binds a sequence of DNA or a zinc finger.
Alternatively, the cognate molecule may be an antibody which recognises an antigen, an enzyme binding a particular substrate or a receptor binding a ligand, or vice versa.
Molecular recognition has been exploited in many laboratory techniques. For example, in western blotting, separated biomolecules may be transferred from one substrate to another for subsequent interrogation with a cognate. However, while this transfer may retain the spatial organisation from the first substrate, it does not allow repeated transfer of, say, a close-packed addressable array of biomolecules.
WO-A-93/17126 discloses a binary oligonucleotide array, and the transfer of hybridised oligonucleotides, by a blotting technique. The transfer is non-specific. A non-specific transfer of colony material, using a colony lift membrane, is disclosed in US-
A-5491068.
WO-A-95/12808 discloses the selective transfer of DNA from solution to different binding locations, by applying a relatively positive potential, and then arelatively negative potential, at one location. The first step of the process binds target and non- ’ target DNA; the second releases non-target DNA.
US-A-5795714 discloses a method for transferring, to a second surface, a DNA f molecule complementary to an arrayed DNA molecule. Transfer is carried out by bringing the second surface into direct contact with a solution comprising the complementary DNA, the solution being contained within discrete vials present on a first
- ? - E 2 oo ) substrate. The preferred embodiment requires the use of avidin/biotin interactions to aid i transfer. The method relies on diffusion to transfer the complementary DNA. Any lateral diffusion will limit the resolution that may be achieved when carrying out transfer from 7 high density arrays. :
According to the present invention a method for producing an array of molecules immobilised on a substrate, comprises the steps of: forming a hybrid array from an array of first molecules immobilised on a first substrate and second molecules, i.e. the molecules to be immobilised, thereby defining a spatial array of the second molecules; bringing into close proximity the first substrate and a second substrate, wherein the second substrate and the second molecules can be mutually linked; by linking them, causing the second molecules to be printed onto the second substrate while retaining the spatial array; and separating the respective substrates.
Inone preferred embodiment of the invention, molecules of a particular class can be attached to a surface using a strong linkage such as a covalent bond to form a spatially addressable array. If this surface is then exposed to a variety of different cognates and allowed to reach near equilibrium, then a cognate will bind to the molecule on the surface for which it has the strongest affinity. Unbound molecules can then be removed by washing. Since the cognate is only attached to the molecule it recognises by non- covalent interactions, it can be transferred to a second surface in close proximity by applying a suitable electric field (under conditions where it has a net positive or negative charge).
Inanother preferred embodiment of the invention, the cognates include a covalent or non-covalent coupling group at one terminus. After contacting the molecules on the surface, the cognates can be transferred to a second surface by contact printing. The : second surface should be first treated to include complementary covalent or non-covalent coupling groups to react with those on the cognate terminus. No electric charge is ! required to effect transfer.
® WO 00/27521 PCT/GB99/03691 ) Thus, if the first surface has particular regions each containing different molecules, the cognate molecules can be printed onto the second surface to produce a : spatial array of cognates. It is preferable, but not essential, for the cognates to bind to } the second surface with high affinity; this is only essential if it is desired to repeat the process on the arrayed cognates, to form a molecular positive array, e.g. to form a copy of the original array. For example, a stronger bond may be formed by forming a covalent bond between the cognates and the second surface or through a strong non-covalent interaction, e.g. an avidin-biotin bond.
The novel method is applicable to both single molecule and many molecule arrays, i.e. arrays of distinct individual molecules and arrays of distinct regions each comprising multiple copies of one individual molecule. The advantages of this method are numerous.
In particular, it means that only one spatially addressable array needs to be made, and then multiple copies can be made for screening and diagnostics.
The molecule array may be characterised prior to printing. For example, the array may be spatially addressed by, say, sequencing, so that each molecule on the array is known.
The first or master molecule array used in this invention may comprise proteins immobilised on a solid surface, e.g. antibodies or enzymes. The proteins are capable of interacting with other molecular species (cognates), e.g. proteins, small molecules or polynucleotides which may then be transferred to a second substrate. For example, the arrayed proteins may be zinc finger proteins which are capable of binding polynucleotides with sequence selectivity; see Choo ef al, PNAS USA, 91:11163 (1994). In certain circumstances, the cognates may not be known, and further characterisation may be required to determine precisely what activity or function the cognate performs.
Alternatively, the arrayed molecules may be polynucleotides. The term . "polynucleotide" is used herein to refer to DNA, RNA and synthetic derivatives or mimics capable of interacting with DNA and RNA, e.g. thioates, amidates and PN As. ' Whatever the molecules in the first array, the term "cognate" is used herein to refer to a molecule that has specific recognition for a molecule different in structure to itself, The respective molecules will typically have complementary portions.
In particular, this invention allows multiple copies of a molecule (e.g. DNA or ]
RNA) array to be produced from a single molecule array (e.g. polynucleotide array) : (master copy) which may be spatially addressed. This method is based on making the : complementary (say) DNA to DNA onthe array, e.g. using DNA polymerase or by direct . hybridisation from a mixture of oligonucleotides, so that the complementary DNA is hybridised to the original DNA in the array, and then printing the complementary DNA onto a second surface. In this step, a second substrate is brought into proximity with the hybrid array, then, e.g. by charging the second substrate, the complementary polynucleotides are printed on it.
In a separate embodiment of the invention, it is possible that the transferred molecule is not the cognate per se, but, rather, is a product of a reaction between the cognate and arrayed molecule. For example, the arrayed molecule may be an enzyme which reacts with its substrate (cognate) to form a product. As this is a localised effect, it will be possible to transfer the product onto the second surface. In this case, the product may be understood as the molecule to be transferred.
In a related embodiment, the arrayed molecule may "capture" its cognate but the cognate undergoes reaction with a further substrate, and the product of this reaction is transferred to the second surface. For example, the arrayed molecule may capture a specific enzyme in a manner that retains the active site. The product of the enzyme- catalysed reaction is then transferred to the second substrate.
In a further embodiment, the first and second molecules may not hybridise directly. Indirect associations may comprise phage-bacterium-phage or antibody-cell- antibody interactions (examples of the invention in which the respective arrayed molecules may be the same, or different).
By way of illustration only, the invention will be now described with reference to
DNA polynucleotides, and to spatially addressable arrays. The production and uses of such arrays are described in PCT/GB99/02487, the contents of which are incorporated ' herein by reference. The density of such arrays may be at least 10%, e.g. at least 10° or 10° entities/cm’, up to 10° entities/cm? or more, and comprising the same or different molecules optionally immobilised on beads (which can typically be c. 1 pm beads, packed
® WO 00/27521 PCT/GB99/03691 ) at a density of 10* per cm®). The fact that the molecules can be different gives broad applicability to the invention.
In one embodiment of the invention, a DNA array, e.g. on glass or silicon, is , copied by hybridisation of a library of single-stranded DNA, under conditions such that members of the library hybridise to their complement strands of DNA on the array.
Alternatively, an array complementary to the master copy is made by enzymatic synthesis using a DNA polymerase and a suitable primer and dNTP's.
Once the DNA array has been made, any non-hybridised DNA may be removed by washing. This results in all or most of the DNA in the spatially addressable array being hybridised to its complementary DNA. The complementary array can now be transferred and attached to the second substrate.
The respective means of attachment of DNA to the first and second substrates should preferably be orthogonal, in order to achieve clean transfer. If the same means was used, transfer might not occur in the event that the complementary DNA can bind to the master. Assuming that this can be prevented, the respective attachments can be of similar or different strengths provided that each is greater than the hybridisation strength of the DNA-DNA duplex. The latter can of course be reduced by destabilising it, by known procedures such as heating, or by changing salt concentration.
The DNA in the original array is preferably attached to the first substrate surface by a strong bond such as a covalent bond or via avidin-biotin which has similar strength ‘to a covalent bond. In order to achieve bonding to the second substrate, the complementary DNA preferably has a terminal group that is chemically-reactive, or activatable, so that it reacts with, and thus becomes attached to, the second substrate surface. When the DNA hybrid is formed, this terminal group may be positioned so that itis furthest away from the surface of the first substrate. For example, the terminal group may be biotin or avidin, in which case the second substrate surface is covered in a layer ’ of avidin or biotin, respectively, for attachment. An example of an activatable group is "caged" biotin, and this can be photoactivated, during the transfer process, to achieve ' printing on the second substrate. When the respective substrates are separated, the relatively weak bond between the hybridised molecules is broken and the respective molecules are held by the respective substrates. Spatial resolution is maintained.
As indicated above, transfer may be achieved without contacting the second substrate with the cognates in the hybrid array, but under an electric field. In this case, both surfaces should be conducting. The first surface may be a metal or doped semiconductor such as silicon. The master array may be attached to the surface bya . covalent linkage (preferred) or a strong specific interaction. Since the specificinteraction with the cognate molecules often includes a number of hydrogen bonds, the transfer may be performed in an electrolyte; for example, a DNA duplex is stable in salt solution but unstable in pure water.
On application of a sufficiently strong field, the cognates will transfer from the hybrid array to the other and can then be anchored to the copy surface via a specific interaction. In addition, ions will move towards the electrodes, positive ions to the negative electrode and vice versa. This electrolysis may damage the master array if it proceeds for too long. In order to keep the potential required low and to ensure good spatial transfer, the electrodes can be spaced apart by non-conducting spacers such as
Teflon, e.g. by 0.1-10 um, often 5-10 um, i.e. as close as possible without shorting of the electrodes. A potential of 1 mV to 1 V may be applied to the electrodes for a short period, e.g. 1 ms to 1 s, for transfer of the cognates from the master to the copy, without causing any damage of the master. The potential and time will depend on the spacing between the electrodes and the electrolyte ionic strength and can be optimised. The polarity ofthe potential applied will depend on the charge on the cognates. The cognates can be attached to the copy electrode by either non-specific interactions or by having a suitable layer of molecules on the electrode and a suitable group on the cognates, so that a specific bond can be formed once the transfer has occurred.
The second substrate is preferably a semiconductor, e.g. silicon or a gold-coated surface. The transfer may be done in the presence of a material that mediates the transfer of the complementary polynucleotides, e.g. a polymer gel or a thin film of, say, water or some other suitable liquid (although transfer in air or in a vacuum may also be possible). '
Solution conditions or heating of the array during the printing process may help ensure good transfer.
Printing on the second substrate may be facilitated by any suitable means. For example, the second substrate is or can be charged. Charging may be by static electricity.
® Wo 00/27521 PCT/GB99/03691 : Preferably, a positive potential is applied to the semiconductor surface, by means of a suitable source of voltage. The effect of this is to attract the negatively-charged : phosphate backbone of the hybridised DNA and pull it onto the semiconductor surface.
As has already been demonstrated, hybridised DNA can be removed at a modest potential, of 300 V.m™; see PNAS USA 94:119 (1994).
It is very desirable that the surfaces of the respective substrates are close together, in order to obtain exact copying and for there to be no problem of adjacent elements in the array switching position during the printing process. Closeness also makes it much easier to produce a sufficiently strong electric field, to attract the hybridised DNA onto the surface of the second substrate.
Any semiconductor or insulator surface that can be sufficiently polarised to attract the hybridised DNA is suitable. The second substrate may also be, say, a thin layer of glass such as a coverslip, used with a metal or other electrode directly behind it, in order to apply the positive potential. The second substrate is preferably not a metal, since that may quench any fluorescence when the array is used with fluorescent probes.
In an alternative aspect of the invention, the transfer may be effected merely by bringing the two surfaces together, so that the second surface can bond directly to the "molecules to be transferred. No applied field is necessary. In this method it is desirable for the cognates to have a coupling group attached with a complementary coupling group attached to the second surface. Therefore, transfer is mediated by the interaction between the respective coupling groups, providing deformed points of attachment, and spatial integrity is maintained. | Suitable coupling groups are as defined above, i.e. biotin/avidin, thiol linkers, etc.
The surfaces of both substrates should be as flat as possible. Suitable silicon wafers are readily available.
Either or each substrate may comprise beads to which the DNA is attached. In , this case, the beads may be used to keep the two surfaces apart; one surface may be placed directly on top of the other, their separation being defined by the diameter of the : beads.
Beads are particularly preferable when the process uses contact printing without any electric charge. The presence of the beads between the two surfaces will facilitate transfer since the contact will be between the top of the bead and the surface onto which ] printing is taking place. It may also be beneficial to have a non-rigid surface, for example by reducing the thickness of the substrate or by using a material that is deformable e.g. : thin plastics. .
Following transfer, the original, master copy of DNA, which is attached by a stronger bond to the surface of the first substrate than to the complementary DNA, remains attached. The complementary DNA is printed onto the second substrate which is then removed, leaving the original master array intact, ready for further printing, If necessary or desired, this process may be repeated on the complementary DNA copy, to obtain an exact copy of the original array.
In this context, reference may be made to Fig. 1. This shows a first substrate 1 carrying beads 2 on which there is an array of DNA molecules 3. The DNA molecules 3 are covalently attached to the beads. Complementary DNA molecules 4 have a reactive functionality 5. A second substrate 6 is modified to carry groups 7 that react with the complementary DNA molecules, to bind them covalently.
It will be apparent to the skilled person that the methods of the present invention can be applied to any molecular species involved in molecular recognition. For example, antibody-antigen recognition may be adapted in the invention, DNA binding proteins may also be used, either as the immobilised template array, or as the cognate molecules, and enzymes and their substrates may also be used.
It will also be apparent that a principal advantage of this method is that only one master array needs to be made and then multiple copies can then be printed. This will greatly increase the speed of production of arrays, and enable them to be widely used for diagnostics, genotyping and expression monitoring.
The following Example illustrates the invention.
Preparation of Glass Slides '
Glass slides to which DNA was to be transferred were cleaned by immersion in 1:1 conc. HCI:MeOH for 1 h, rinsed in Milli-Q water, immersed in conc. H,SO, for 1h and rinsed in water again. Cleaned slides were stored in mQ water.
. ® WO 00/27521 PCT/GB99/03691 i 9 ) The slides were silanised with amino-functionalised silane reagent,
N-[3-(trimethoxysilyl)propyljethylenediamine (DETA). Silanisation of cleaned glass ! substrates was performed using a 1% solution of DETA in 1 mM glacial acetic acid for 1 h. The slides were rinsed with mQ water, dried with N, and baked at 120°C for 5 minutes.
The silanised slides were then reacted with SMCC, a heterobifunctional linker capable of reacting with amine and thiol groups (see Fig. 2). 15 mg (45 umoles) SMCC was dissolved in 200 pl DMSO. This was diluted to 120 ml in 80:20 MeOH:DMSO.
Silanised slides were immersed in the solution for 3 h at RT, then rinsed well with mQ water and dried under N,. The maleimide-derivatised slides were stored in a vacuum desiccator.
Control Experiment
A slide was tested to ensure that the maleimide surface was reactive towards thiols. A 5-SH, 3'TMR 20-mer oligonucleotide (SEQ ID No. 1) was used. DTT was removed from the sample (as it will interfere with the reaction) by passing the sample down a NAP-5 gel filtration column. 500 pl of the thiol oligo solution was placed on an
SMCC-reacted glass slide, and 500 pl on a control glass slide, and placed in a humid environment for 2 h at RT. The slides were then rinsed in mQ-water and placed in SPSC buffer (50 mM NaP, 1 M NaCl) for 12 h, in order to remove any DNA that was not covalently attached to the surface. The slides were rinsed, dried under N,, and visualised with a FluorImager (488 nm excitation, 570 nm filter).
Transfer
An ethanol solution of 1.0 um silica beads, to which was attached a 20-mer DNA sequence (SEQ ID No. 2), was spotted onto a cleaned glass slide, and the EtOH allowed to evaporate to form a monolayer of beads. 5 such slides were prepared. 25 pl ofa 10 uM solution of the 5'-SH, 3'-TMR in 10 mM KPi, 100 mM NaCl, 1 mM DTT was added ‘ to the circular patch of beads on each slide and allowed to hybridise for 1 hat RT. The slide was rinsed well (5 x 5 ml washes) with buffer (10 mM KPi, 100 mM NaCl) in order to remove DTT and unhybridised oligo. The reactive SMCC-derivatised slides were then carefully placed over the slide having the hybridised duplex on the beads. 0, 1, 2, 3 and 4 extra glass slides were placed on top of the respective SMCC slides, in order to increase the weight, and therefore the amount of contact, with the beads. The slides were ) placed in a humid environment for 2 h at RT, after which the reactive top slide was carefully removed and placed in SPSC buffer for 12 h to remove any oligo not covalently ¢ attached to the surface. The slides were rinsed, dried and visualised using the
Fluorlmager (at 488 nm excitation). ‘Results
DNA transfer from the beaded array to the glass surface has been achieved. The circular images observed correspond to the shape of the original patch of beads on the surface. Based on the control experiment, the observed fluorescence can only represent fluorescent oligonucleotide that has been transferred from the beaded array and covalently attached to the opposite surface.
Claims (19)
1. A method for producing an array of molecules immobilised on a substrate, which : comprises the steps of: forming a hybrid array from an array of first molecules immobilised on a first substrate and second molecules, i.e. the molecules to be immobilised, thereby defining a spatial array of the second molecules; bringing into close proximity the first substrate and a second substrate, wherein the second substrate and the second molecules can be mutually linked; by linking them, causing the second molecules to be printed onto the second substrate while retaining the spatial array; and separating the respective substrates.
2. A method according to claim 1, wherein, in the hybrid array, the first and second molecules are indirectly associated.
3. A method according to claim 1, wherein the first and second molecules include complementary portions.
4. A method according to any preceding claim, wherein the first molecules are proteins.
5. A method according to any preceding claim, wherein the second molecules are proteins, e.g. zinc finger proteins.
6. A method according to claim 3, wherein the first and second molecules are polynucleotides.
7. A method according to claim 6, wherein the second molecules comprise a library of single-stranded polynucleotides.
8. A method according to claim 6, wherein the second molecules in the hybrid array are formed in situ, using a polymerase and the nucleotide triphosphates.
9. A method according to any preceding claim, wherein the linking comprises covalent or avidin-biotin binding.
10. A method according to any preceding claim, wherein the first molecules are immobilised on microscopic beads bound to a solid support.
11. A method according to any preceding claim, wherein the second substrate and the ) second molecules are brought into contact and linked, and the respective substrates are then separated. :
12. A method according to any of claims claim 1 to 10, wherein the second molecules are printed onto the second substrate under the application of an electric field.
13. A method according to claim 12, which additionally comprises introducing, between the first and second substrates, a material that mediates the transfer of the second molecules from the hybrid array to the second substrate.
14. A method according to claim 12 or claim 13, wherein one or each substrate comprises a semiconductor surface.
15. A method according to claim 14, wherein the semiconductor surface comprises silicon.
16. A method according to any preceding claim, wherein the facing surfaces of the respective substrates are flat.
17. A method according to any preceding claim, wherein either or each array comprises a plurality of different molecules, at a density of at least 10° per cm?.
18. A method for producing a copy of an array of first molecules immobilised on a first substrate, which comprises the steps of any preceding claim, and repeating those steps using the first molecules to form the hybrid array and a third substrate on which to print the first molecules.
19. A method according to any preceding claim, which is repeated any desired number of times, thereby producing a plurality of copies of immobilised molecules having the spatial array.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9824441.1A GB9824441D0 (en) | 1998-11-06 | 1998-11-06 | A method for reproducing polynucleotide arrays |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200103483B true ZA200103483B (en) | 2002-05-10 |
Family
ID=10842039
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200103483A ZA200103483B (en) | 1998-11-06 | 2001-04-30 | A method for reproducing molecular arrays. |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB9824441D0 (en) |
ZA (1) | ZA200103483B (en) |
-
1998
- 1998-11-06 GB GBGB9824441.1A patent/GB9824441D0/en not_active Ceased
-
2001
- 2001-04-30 ZA ZA200103483A patent/ZA200103483B/en unknown
Also Published As
Publication number | Publication date |
---|---|
GB9824441D0 (en) | 1999-01-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU758630B2 (en) | A method for reproducing molecular arrays | |
JP4479960B2 (en) | Methods and apparatus for protein delivery into cells | |
Weng et al. | Generating addressable protein microarrays with PROfusion™ covalent mRNA‐protein fusion technology | |
EP1951913B1 (en) | Process to detect binding events on an electrode microarray using enzymes | |
Hook et al. | Surface manipulation of biomolecules for cell microarray applications | |
JP3670019B2 (en) | Apparatus for aligning macromolecules in parallel and use thereof | |
US20100009872A1 (en) | Single molecule loading methods and compositions | |
US20010024788A1 (en) | Method for producing nucleic acid strand immobilized carrier | |
IL124322A (en) | Detection of an entity in a sample | |
JP2004525345A (en) | Immobilized microarray of biological or chemical probes immobilized on a support by magnetic force | |
NZ279861A (en) | Specific surface for biological reactions comprising a support having a surface compact layer of an organic compound with an exposed affinity group containing an ethylenic double bond | |
WO2008020813A1 (en) | Method of electrically detecting a biological analyte molecule | |
JP2002531098A (en) | Cloning and copying on surface | |
JP2006330000A (en) | Improved biochip | |
Zacco et al. | Electrochemical biosensing based on universal affinity biocomposite platforms | |
CN104535769A (en) | Method for preparing bio-macromolecular monomolecular chip by virtue of high-density nano-hollow | |
JP5883386B2 (en) | Protein or peptide printing method, protein array or peptide array production method, and functional protein or functional peptide identification method | |
US9266726B2 (en) | Method for making biochips | |
US20040121339A1 (en) | Special film-coated substrate for bio-microarray fabrication and use thereof | |
Kant et al. | Relevance of adhesion in fabrication of microarrays in clinical diagnostics | |
ZA200103483B (en) | A method for reproducing molecular arrays. | |
Heyries et al. | Direct poly (dimethylsiloxane) surface functionalization with vinyl modified DNA | |
Marquette et al. | Biochips: non-conventional strategies for biosensing elements immobilization | |
JP2001330608A (en) | Method for manufacturing nucleic acid chain immobilizing carrier | |
US7919332B2 (en) | Biological molecule-immobilized chip and its use |